Please wait

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Name of Issuer)

(Title of Class of Securities)

(CUSIP Number)

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13D/A 0001104659-22-001308 0001902511 XXXXXXXX LIVE 5 Common Shares, par value $0.0001 01/03/2025 false 0001720420 G4690M101 IBEX Ltd 1717 Pennsylvania Avenue NW Suite 825 Washington DC 20006 William Corson (646) 857-8000 65 East 55th Street New York NY 10022 0001984825 PineBridge Global Emerging Markets Partners II, L.P. b OO E9 0 1255363 0 1255363 1255363 N 9.5 PN 0001902511 PineBridge GEM II G.P., L.P. b E9 0 1255363 0 1255363 1255363 N 9.5 PN 0001974212 Leone John b OO X1 0 1255363 0 1255363 1255363 N 9.5 IN 0001984821 Mellinger Pierre b OO I0 0 1255363 0 1255363 1255363 N 9.5 IN 0001984823 Clowe Kevin OO X1 0 1255363 0 1255363 1255363 N 9.5 IN Common Shares, par value $0.0001 IBEX Ltd 1717 Pennsylvania Avenue NW Suite 825 Washington DC 20006 This Amendment No. 5 to Schedule 13D ("Amendment No. 5") is being filed by the undersigned, pursuant to Rule 13d-2(a), to amend and supplement the Schedule 13D filed with the U.S. Securities and Exchange Commission (the "SEC") on January 5, 2022, as amended by Amendment No. 1 filed with the SEC on September 17, 2024, Amendment No. 2 filed with the SEC on October 4, 2024, Amendment No. 3 filed with the SEC on November 22, 2024 and Amendment No. 4 filed with the SEC on December 6, 2024 (collectively, the "Schedule 13D"), with respect to the common shares, $0.0001 par value (the "Common Shares"), of IBEX Limited (the "Issuer"), whose principal executive offices are located at 1717 Pennsylvania Avenue NW, Suite 825, Washington, DC 20006. Except as specifically provided herein, this Amendment No. 5 does not modify any of the information previously reported in the Schedule 13D. Capitalized terms used but not defined in this Amendment No. 5 shall have the meanings given to them in the Schedule 13D. Item 5(a) - (c) of the Schedule 13D is hereby amended and supplemented as follows: GEM II is the record owner of 1,255,363 Common Shares. As the sole director of PineBridge GEM II GP Ltd., which is the sole general partner of GEM II, GEM II GP may be deemed to beneficially own the Common Shares directly owned by GEM II. As members of the Investment Committee, each of the Investment Committee Members may be deemed to beneficially own the Common Shares directly owned by GEM II. PineBridge GEM II G.P., Co., a Cayman Islands company, is the sole general partner of GEM II GP. PineBridge GEM II G.P., Co. is a wholly-owned subsidiary of PineBridge Investments Partners LLC, a Delaware limited liability company that is a wholly-owned subsidiary of PineBridge Investments, L.P., a Cayman Islands partnership ("PILP"). The General Partner of PILP is Bridge Holdings Company Limited ("Bridge Holdings"). Bridge Holdings is wholly owned by Pacific Century Investment Holdings No. 1 Limited ("PCIH No. 1"). PCIH No. 1 is wholly owned by ChiltonLink Limited, which, in turn, is wholly owned by Richard Li. Each of PineBridge GEM II G.P., Co., PineBridge Investments Partners LLC, PILP, Bridge Holdings, PCIH No. 1, ChiltonLink Limited, and Richard Li disclaims beneficial ownership of the Common Shares directly owned by GEM II. The percentage of outstanding Common Shares of the Issuer which may be deemed to be beneficially owned by each Reporting Person is set forth on Line 13 of such Reporting Person's cover sheet. Such percentage was calculated based on 16,764,808 Common Shares outstanding as of October 31, 2024, as reported in the Issuer's quarterly report on Form 10-Q filed with the SEC on November 7, 2024, minus 3,562,341 Common Shares that the Issuer repurchased on November 19, 2024, as reported in the Issuer's current report on Form 8-K filed with the SEC on November 20, 2024. (i) sole power to vote or to direct the vote: See line 7 of cover sheets (ii) shared power to vote or to direct the vote: See line 8 of cover sheets (iii) sole power to dispose or to direct the disposition: See line 9 of cover sheets (iv) shared power to dispose or to direct the disposition: See line 10 of cover sheets Except for the transactions listed in Exhibit 11 of this Amendment No. 5, the Reporting Persons have not effected any transactions with respect to the Common Shares since the filing of Amendment No. 4 on December 6, 2024. Item 7 of the Schedule 13D is hereby amended and supplemented as follows: Exhibit 11 - Schedule of Transactions for Item 5(c) of Amendment No. 5. PineBridge Global Emerging Markets Partners II, L.P. /s/ John Leone By: PineBridge GEM II GP Ltd., its GP, By PineBridge GEM II G.P., L.P., its sole director, By PineBridge GEM II G.P., Co., its GP, By: John Leone, VP 01/07/2025 PineBridge GEM II G.P., L.P. /s/ John Leone By: PineBridge GEM II G.P., Co., its general partner, By: John Leone, Vice President 01/07/2025 Leone John /s/ John Leone John Leone 01/07/2025 Mellinger Pierre */s/ Lindsay Johnson Lindsay Johnson as attorney-in-fact 01/07/2025 Clowe Kevin */s/ Lindsay Johnson Lindsay Johnson as attorney-in-fact 01/07/2025 *This Schedule 13D was executed by Lindsay Johnson on behalf of the individuals listed above pursuant to a Power of Attorney, a copy of which is attached as an exhibit to the amendment to Form 3 filed by GEM II, GEM II GP, Mr. Mellinger and Mr. Clowe on July 13, 2023.